Objectives

After participating in this educational activity, attendees should be able to:

1|Understand the mechanism of immune therapy as it relates to treating oncologic conditions
2|Describe the mechanism of immune related adverse events (irAEs), clinical presentation, and the role of the pharmacist
3|Identify organ systems affected and review reversable versus permanent (irAEs)
4|Create a patient-specific treatment plan to manage the irAE's presented throughout the clinical course of the patient case
Faculty

Erin Persico, PharmD
PGY1 Pharmacy Resident
Department of Pharmacy Services
Pharmacist
Baystate Medical Center 

Faculty Disclosure

The design and content of Baystate Continuing Interprofessional Education (CE) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options. Any relevant financial relationships are mitigated prior to the educational activity.

None of the planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. 

Accreditation Statement
In support of improving patient care, Baystate Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Pharmacists
Baystate Health designates this activity for a maximum of 1.0 contact hours (s) for pharmacists. Pharmacists should claim only the credit commensurate with the extent of their participation in the activity. 

Session date: 
01/09/2023 - 2:00pm to 3:00pm EST
Location: 
Webinar
Baystate Medical Center
759 Chestnut St
Springfield, MA 01199
United States
  • 1.00 ACPE Contact Hours
  • 1.00 BCIPE Instructional Hours

Please login or register to take this course.